INDiGO® is the new accelerated drug development service launched by Evotec; the new solution aims to reduce the time and cost of pre-clinical drug development whilst delivering a high-quality data package for CTA/IND level regulatory filings. Typical activities managed by the platform include API manufacture, formulation development, clinical supply, safety assessment, DMPK, bioanalysis and biomarkers, and regulatory submission documents preparation


Please enter your comment!
Please enter your name here